JPMorgan Chase & Co. Cuts Procter & Gamble (NYSE:PG) Price Target to $157.00

Procter & Gamble (NYSE:PG) had its price objective cut by JPMorgan Chase & Co. from $165.00 to $157.00 in a research note published on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

Other analysts also recently issued reports about the stock. BNP Paribas Exane lowered their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Jefferies Financial Group upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price target for the company from $156.00 to $179.00 in a research note on Tuesday. Wells Fargo & Company cut their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Dbs Bank upgraded Procter & Gamble to a “hold” rating in a report on Friday, December 5th. Finally, Raymond James Financial dropped their target price on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $171.38.

Procter & Gamble Price Performance

PG stock opened at $144.39 on Thursday. The stock has a 50-day moving average price of $147.32 and a two-hundred day moving average price of $153.46. Procter & Gamble has a 1 year low of $138.14 and a 1 year high of $179.99. The stock has a market cap of $337.41 billion, a PE ratio of 21.08, a price-to-earnings-growth ratio of 4.86 and a beta of 0.39. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.The company had revenue of $22.39 billion during the quarter, compared to analysts’ expectations of $22.23 billion. During the same period in the prior year, the firm earned $1.93 earnings per share. Procter & Gamble’s revenue for the quarter was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities analysts forecast that Procter & Gamble will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Friday, October 24th. Procter & Gamble’s payout ratio is 61.75%.

Insider Buying and Selling

In other news, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the transaction, the chief executive officer directly owned 61,764 shares in the company, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Matthew W. Janzaruk sold 725 shares of the stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the completion of the sale, the chief accounting officer owned 979 shares in the company, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 30,308 shares of company stock valued at $4,611,852. Insiders own 0.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Halbert Hargrove Global Advisors LLC bought a new position in shares of Procter & Gamble during the third quarter worth approximately $25,000. Nova Wealth Management Inc. acquired a new position in Procter & Gamble in the 1st quarter valued at $26,000. Signature Resources Capital Management LLC grew its holdings in Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after buying an additional 72 shares in the last quarter. Saranac Partners Ltd bought a new position in Procter & Gamble during the 3rd quarter worth $30,000. Finally, Corundum Trust Company INC acquired a new stake in shares of Procter & Gamble during the third quarter worth $32,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.